Skip to content
Kalpvruksh Markets
Offline Log in

STARNSEOffline

STRIDES PHARMA SCIEN · INE939A01011 · Small Cap · #588
1,007.60−6.60 (−0.65%)last close · 05 Nov 2026
Prev close
1,014.20
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹9,023 cr
52-week range · to 05 Nov 2026793.551,235.1

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

STAR is 18% below its 52-week high, below its 200-day average — a Small Cap company, #588 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • below its 20 / 50 / 200-day averages · 18% below its 52-week high
  • +6.1% vs Nifty 500
  • traded value 3.3× usual · delivery 47% vs 47% usual
  • FPI −0.4 pp · DII +0.1 pp · MF schemes in Sept 2026: 4 bought, 5 cut · promoter pledge 33.8% · quarter ended 2026-09-30
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹9,023 cr
Rank
#588
Cap band
Small Cap
Nearest cut-off — Mid / Small
−73.61% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.6×
median 1,41,294
Delivered
2,30,001
Of volume
51%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week−8.2%−13.3 pts—
1 month−7.4%−11.5 pts—
3 months+3.8%+6.1 pts—
6 months−8.2%−8.6 pts—
1 year+18.2%+21.3 pts—

Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
−4.5%
below
vs 50-day average
−8.2%
below
vs 200-day average
−1.3%
below
ATR (14)
4.5%
typical daily range
Volatility
32%
1 month, annualised
Beta
0.60
vs Nifty 500, 1 year
Traded value
3.3×
vs usual
Delivery
47%
usual 47%
From the 52-week high
−18.4%
place in range 48% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters27.9%27.9% +0.127.9%29.0% +1.1
FPI29.5%28.7% −0.828.4% −0.328.0% −0.4
Mutual funds8.6%8.6%8.7% +0.210.3% +1.6
Other DII4.4%5.9% +1.56.7% +0.85.2% −1.5
Individuals21.4%20.8% −0.620.4% −0.419.7% −0.7
Others8.2%8.2%7.9% −0.37.8%

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
33.8%
Of all shares
9.8%
Jun 25 50.1%Sep 25 44.1%Dec 25 30.6%Mar 26 27.3%Jun 26 38.1%Sep 26 33.8%

Holders

Sep 26

All shareholders
93,336
Individuals
87,907

Indian passive funds’ stake

2026-06-30

Of free float
0.28%
Of all shares
0.20%
Schemes
9
Days to unwind
0.5
at 100% of volume

1,86,779 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
18
9 index · 9 active
Bought more
7
Sold some
5
FundSharesChangeDid
Quant Small Cap Fund(G)Active+76,076+2.1%bought
WOC Pharma and Healthcare Fund-Reg(G)Active−15,625−21.2%sold
Samco Multi Cap Fund-Reg(G)Active−1,992−14.9%sold
Motilal Oswal Nifty Microcap 250 Index Fund-Reg(G)Index−16,204−8.2%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 26120450+7.2%₹777 cr
Aug 26120412−0.0%₹664 cr
Jul 26140231−1.0%₹664 cr
Jun 26150341−0.4%₹715 cr
May 26160620+1.8%₹730 cr
Apr 26164521+1.5%₹669 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Strides Pharma Science Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    30 Oct 2026
  • Board outcome
    Strides Pharma Science Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    31 Jul 2026
  • Bulk deal: BUY
    6,62,369 at ₹1,045.28 — SBI LIFE INSURANCE COMPANY LIMITED
    30 Oct 2026
  • Bulk deal: BUY
    10,00,000 at ₹990 — ARUN KUMAR PILLAI
    28 Aug 2026
  • Bulk deal: SELL
    10,00,000 at ₹990 — SBI LIFE INSURANCE CO.LTD.
    28 Aug 2026
  • Block deal: BUY
    10,00,000 at ₹990 — ARUN KUMAR PILLAI
    28 Aug 2026

Latest shown; 7 in six months on all disclosures.

STAR: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹5Final31 Jul 202631 Jul 2026
EarlierDividend₹4Final22 Jul 202522 Jul 2025
EarlierDividend₹2.5Final09 Sept 202409 Sept 2024
EarlierDividend₹1.5Final04 Aug 202304 Aug 2023

4 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.